Log in

Davita Stock Forecast, Price & News

-2.20 (-2.52 %)
(As of 09/21/2020 12:00 AM ET)
Today's Range
Now: $85.12
50-Day Range
MA: $86.16
52-Week Range
Now: $85.12
Volume1.40 million shs
Average Volume1.30 million shs
Market Capitalization$10.38 billion
P/E Ratio13.43
Dividend YieldN/A
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2018, it provided dialysis and administrative services in the United States through a network of 2,664 outpatient dialysis centers serving approximately 202,700 patients; and operated 241 outpatient dialysis centers located in 9 countries outside of the United States serving approximately 25,000 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Read More
Davita logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services



Sales & Book Value

Annual Sales$11.39 billion
Cash Flow$10.94 per share
Book Value$18.10 per share


Net Income$810.98 million


Market Cap$10.38 billion
Next Earnings Date11/3/2020 (Estimated)
-2.20 (-2.52 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Davita (NYSE:DVA) Frequently Asked Questions

How has Davita's stock price been impacted by Coronavirus (COVID-19)?

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DVA stock has increased by 13.7% and is now trading at $85.12.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Davita?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Davita

When is Davita's next earnings date?

Davita is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Davita

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) released its quarterly earnings results on Thursday, July, 30th. The company reported $1.95 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.30 by $0.65. The firm earned $2.88 billion during the quarter, compared to analyst estimates of $2.91 billion. Davita had a return on equity of 40.78% and a net margin of 7.20%.
View Davita's earnings history

What guidance has Davita issued on next quarter's earnings?

Davita issued an update on its FY20 earnings guidance on Thursday, July, 30th. The company provided earnings per share (EPS) guidance of $6.25-$6.75 for the period, compared to the Thomson Reuters consensus estimate of $6.11. The company issued revenue guidance of $11.5-$11.7 billion, compared to the consensus revenue estimate of $11.70 billion.

What price target have analysts set for DVA?

8 brokers have issued 12 month price targets for Davita's shares. Their forecasts range from $57.00 to $100.00. On average, they anticipate Davita's stock price to reach $73.40 in the next year. This suggests that the stock has a possible downside of 13.8%.
View analysts' price targets for Davita

Are investors shorting Davita?

Davita saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 5,710,000 shares, an increase of 12.2% from the August 15th total of 5,090,000 shares. Based on an average daily trading volume, of 973,800 shares, the short-interest ratio is presently 5.9 days. Currently, 4.7% of the company's shares are short sold.
View Davita's Short Interest

Who are some of Davita's key competitors?

What other stocks do shareholders of Davita own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), United Rentals (URI), AT&T (T), AbbVie (ABBV) and AutoZone (AZO).

Who are Davita's key executives?

Davita's management team includes the following people:
  • Mr. Kent J. Thiry, Chairman & CEO (Age 63)
  • Mr. Joel Ackerman, Chief Financial Officer (Age 54)
  • Mr. James K. Hilger, Chief Accounting Officer (Age 57)
  • Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 51)
  • Mr. Javier J. Rodriguez, Chief Exec. Officer of DaVita Kidney Care (Age 48)

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Who are Davita's major shareholders?

Davita's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.28%), Bank of New York Mellon Corp (2.22%), Par Capital Management Inc. (1.71%), Robeco Institutional Asset Management B.V. (1.38%), LSV Asset Management (0.82%) and AQR Capital Management LLC (0.65%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, Paul J Diaz and R Ted Weschler.
View institutional ownership trends for Davita

Which major investors are selling Davita stock?

DVA stock was sold by a variety of institutional investors in the last quarter, including Par Capital Management Inc., Vanguard Group Inc., First Trust Advisors LP, Canada Pension Plan Investment Board, AJO LP, Sumitomo Mitsui Trust Holdings Inc., Prudential Financial Inc., and Glenmede Trust Co. NA. Company insiders that have sold Davita company stock in the last year include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, Paul J Diaz, and R Ted Weschler.
View insider buying and selling activity for Davita

Which major investors are buying Davita stock?

DVA stock was bought by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, LSV Asset Management, Bridgeway Capital Management Inc., AQR Capital Management LLC, Todd Asset Management LLC, Bellevue Group AG, Robeco Institutional Asset Management B.V., and Teachers Retirement System of The State of Kentucky.
View insider buying and selling activity for Davita

How do I buy shares of Davita?

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Davita's stock price today?

One share of DVA stock can currently be purchased for approximately $85.12.

How big of a company is Davita?

Davita has a market capitalization of $10.38 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

What is Davita's official website?

The official website for Davita is www.davita.com.

How can I contact Davita?

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.